multicenter study

Type: Keyphrase
Name: multicenter study
First reported Aug 18 2014 - Updated Aug 18 2014 - 1 reports

Is Fast MRI Better Than Mammography?

This is Dr. Kathy Miller, from Indiana University. I want to draw your attention to a recent edition of the Journal of Clinical Oncology , specifically to an article by Christine Kuhl and associates about fast breast MRI. [1]Many of you know that I have ... [Published General Medicine eJournal - Aug 18 2014]
First reported Aug 14 2014 - Updated Aug 14 2014 - 1 reports

Esperion Therapeutics Provides ETC-1002 Development Program Update; Reports Second Quarter 2014 Financial Results [Global Data Point]

"Top-line results are expected in early October from our Phase 2b ETC-1002-008 clinical trial in statin intolerant patients. Results from our 2-year carcinogenicity studies are anticipated late in the fourth quarter, while top-line results from two additional ... [Published Pharmacy Choice - Aug 14 2014]
First reported Aug 12 2014 - Updated Aug 12 2014 - 1 reports

Esperion Therapeutics Provides ETC-1002 Development Program Update; Reports Second Quarter 2014 Financial Results

ANN ARBOR, Mich.--(BUSINESS WIRE)-- Esperion Therapeutics, Inc. (NASDAQ:ESPR) a clinical-stage biopharmaceutical company focused on developing and commercializing first-in-class, oral, low-density lipoprotein cholesterol (LDL-cholesterol) lowering therapies ... [Published Investor's Business Daily - Aug 12 2014]
First reported Aug 11 2014 - Updated Aug 11 2014 - 1 reports

Understanding Head Lice

A multicenter study will examine whether a drug used to treat rheumatoid arthritis can improve kidney transplant patients’ health.Details on companies affected by the breach are not yet available.Clinical hold on Tekmira’s Ebola treatment changed to partial ... [Published Pharmacy Times - Aug 11 2014]
First reported Aug 10 2014 - Updated Aug 10 2014 - 1 reports

Promise for new nerve repair technique -- ScienceDaily

A multicenter study including University of Kentucky researchers found that a new nerve repair technique yields better results and fewer side effects than other existing techniques.Traumatic nerve injuries are common, and when nerves are severed, they ... [Published DailyMe.Com - Aug 10 2014]
First reported Aug 06 2014 - Updated Aug 07 2014 - 1 reports

A study of the Infectious Diseases group at VHIR receives the Emanuel Wolinsky Award (06/08/2014)

The editors of the prestigious journal Clinical Infectious Diseases have selected a study coordinated by the Infectious Diseases group at Vall d’Hebron Institute of Research (VHIR), to receive the Emanuel Wolinsky Award for the most outstanding clinical ... [Published Vall d'Hebron - Aug 06 2014]
First reported Aug 06 2014 - Updated Aug 06 2014 - 1 reports

Patient Navigation May Benefit Patients with Breast Cancer

the Cancer Therapy Advisor take:Patient navigation is the process of a joining a newly diagnosed patients with cancer with a health care professional who has been specifically trained to guide patients through the complex journey of diagnosis and cancer ... [Published Chemotherapy Advisor - Aug 06 2014]
First reported Aug 06 2014 - Updated Aug 06 2014 - 1 reports

Blau Syndrome, the prototypic auto-inflammatory granulomatous disease

Blau syndrome is a monogenic disease resulting from mutations in the pattern recognition receptor NOD2, and is phenotypically characterized by the triad of granulomatous polyarthritis, dermatitis and uveitis. This paper reviews briefly the classical clinical ... [Published 7thSpace - Aug 06 2014]
First reported Aug 04 2014 - Updated Aug 05 2014 - 3 reports

UAB takes part in $17 million study on kidney transplants

The University of Alabama at Birmingham will take part in a $17 million multicenter study funded over a seven year period by the National Institutes of Health to research how certain drugs and cells used in the treatment of rheumatoid arthritis can help ... [Published Business First of Buffalo - Aug 05 2014]
First reported Aug 04 2014 - Updated Aug 04 2014 - 2 reports

Toward Personalized Medicine for Kidney Transplant Recipients

UC San Francisco is the lead institution on a new seven-year, $17 million multicenter study funded by the National Institutes of Health to determine if certain immune system cells and/or a drug now used for treating rheumatoid arthritis can be effective ... [Published Infrosoft - Aug 04 2014]
First reported Aug 02 2014 - Updated Aug 02 2014 - 1 reports

Iridex Earnings Hold Steady in Second Quarter

MOUNTAIN VIEW, Calif., Aug. 1, 2014 — Iridex Corp. earnings were relatively stable and revenue climbed 15 percent in the second quarter as the company continues to promote its laser eye treatment product.Revenues were $10.6 million, compared to $9.2 million ... [Published Photonics - Aug 02 2014]
First reported Jul 22 2014 - Updated Jul 22 2014 - 2 reports

PSI, AOP Orphan Collaborate on Global Rare Disease Trial

(Source: Wikimedia Commons)PSI CRO, a full-service contract research organization, announced the launch of a new global study in Polycythemia vera in collaboration with AOP Orphan. PSI is setting up this 100-patient open-label, multicenter study at 45 ... [Published Drug Discovery and Development - Jul 22 2014]

Quotes

Benazzato L, D " Inca R, Grigoletto F et al. Prognosis of severe attacks in ulcerative colitis: effect of intensive medical treatment. Dig Liver Dis 2004;36:461–6."
of even-chain saturated fatty acids, Ms. Ginn concluded, "The benefits may not be just about the fat but the whole diet. People eat foods in combination."
"The world's first approved treatment for the underlying cause of DMD marks a very important moment for patients and their families. It is our highest priority to make Translarna available to patients and we will be working with regulators, payers, physicians and patient organizations to make that a reality." stated Mark Rothera , Chief Commercial Officer, of PTC Therapeutics Inc
...two additional Phase 2 studies are expected in the first half of 2015," said Tim M Mayleben, president and chief executive officer of Esperion. "We believe that ETC-1002 is the right drug in development for the treatment of patients with hypercholesterolemia and a history of statin intolerance. This is a patient population that is increasingly recognized as deserving of more effective oral therapy options."

More Content

All (142) | News (118) | Reports (1) | Blogs (21) | Audio/Video (0) | Fact Sheets (0) | Press Releases (2)
sort by: Date | Relevance
Mutation in Cutaneous Lymphoma Linked to Poor P... [Published Cancernetwork.com - 8 hours ago]
Study Finds Increased Rates of Preventable Deat... [Published Health Canal - 18 hours ago]
Comparison of Resource Utilization of Pulmonary... [Published General Medicine eJournal - Aug 19 2014]
Palliative Strategies for Primary and Metastati... [Published General Medicine eJournal - Aug 19 2014]
Infection Management Guidelines and Outcomes in... [Published General Medicine eJournal - Aug 19 2014]
A Personalized Medicine Approach to the Managem... [Published Diabetes Care - Aug 19 2014]
Is Fast MRI Better Than Mammography? [Published General Medicine eJournal - Aug 18 2014]
Stem Cell Transplantation [Published Multiple Sclerosis Research - Aug 17 2014]
A balanced look at gluten sensitivity [Published Science-Based Medicine - Aug 16 2014]
Adult ALL: Studies Show Promise of Both Blinatu... [Published Oncology Times - Aug 14 2014]
Dairy Saturated Fats Lower Type 2 Diabetes Risk [Published General Medicine eJournal - Aug 14 2014]
PTC Therapeutics : Receives Conditional Approva... [Published 4 Traders - Aug 14 2014]
Esperion Therapeutics Provides ETC-1002 Develop... [Published Pharmacy Choice - Aug 14 2014]
Diagnosis and Management of Gastric Neuroendocr... [Published General Medicine eJournal - Aug 13 2014]
Laboratory Test Surveillance following Acute Ki... [Published Plosone.org - Aug 12 2014]
Donning Gloves May Protect Preemies From Infect... [Published American Journal of Public Health - Aug 12 2014]
Alliance Established to Provide Cloud-Based Hea... [Published MedImaging.net - Aug 12 2014]
Esperion Therapeutics Provides ETC-1002 Develop... [Published Investor's Business Daily - Aug 12 2014]
Understanding Head Lice [Published Pharmacy Times - Aug 11 2014]
Alcobra's (ADHD) CEO Yaron Daniely on Q2 2014 R... [Published Seeking Alpha - Aug 11 2014]
Novel molecule shows promise for future treatme... [Published Orthopedics Today - Aug 11 2014]
Genmab Announces New Phase III Study of Daratum... [Published Virtual Strategy Magazine - Aug 11 2014]
Genmab Announces New Phase III Study of Daratum... [Published SPi World News - Aug 11 2014]
Genmab Announces New Phase III Study of Daratum... [Published Stock Nod - Aug 11 2014]
Genmab Announces New Phase III Study of Daratum... [Published EuroInvestor - Aug 11 2014]
Allograft: New nerve repair technique with fewe... [Published ProKerala.com - Aug 11 2014]
Diagnosis and Management of Adult Celiac Disease [Published General Medicine eJournal - Aug 11 2014]
ONLINE FIRST: Disparities Found in Opioid-Presc... [Published Oncology Times - Aug 11 2014]
New brain mechanism study could advance artific... [Published Iran Daily - Aug 11 2014]
Infectious keratitis: The Asian scenario [Published Eye World - Aug 10 2014]
1 2 3 4 5
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Stem Cell Transplantation [Published Multiple Sclerosis Research - Aug 17 2014]
Greco R, Bondanza A, Oliveira MC, Badoglio M, Burman J, Piehl F, Hagglund H, Krasulova E, Simões BP, Carlson K, Pohlreich D, Labopin M, Saccardi R, Comi G, Mancardi GL, Bacigalupo A, Ciceri F, Farge D. Autologous hematopoietic stem cell transplantation ...
A balanced look at gluten sensitivity [Published Science-Based Medicine - Aug 16 2014]
Even though it doesn’t appear on any calendar, May 2014 will go down in history as “gluten sensitivity month.” After RealClearScience picked up on a 2013 paper that brought into question the existence of non-celiac gluten sensitivity (NCGS), news sites ...
Effects of switching to fingolimod [Published Multiple Sclerosis Research - Aug 06 2014]
Fox E et al. Outcomes of switching directly to oral fingolimod from injectable therapies: Results of the randomized, open-label, multicenter, Evaluate Patient OutComes (EPOC) study in relapsing multiple sclerosisDOI: 10.1016/j.msard.2014.06.005 Background ...
Toward Personalized Medicine for Kidney Transpl... [Published UCSF News - Aug 04 2014]
UCSF is the lead institution on a new seven-year, $17 million multicenter study to determine if certain immune system cells and/or a drug can be effective in improving and maintaining the long-term health of kidney transplant recipients. ...
Autologous hematopoietic stem cell transplantat... [Published Multiple Sclerosis Journal RSS feed -- OnlineFi ... - Jul 30 2014]
Background: Neuromyelitis optica (NMO) is an inflammatory autoimmune disorder of the central nervous system, hallmarked by pathogenic anti-aquaporin 4 antibodies. NMO prognosis is worse compared with multiple sclerosis. Objective: The European Group for ...
1 2 3 4 5

Press Releases

sort by: Date | Relevance
Umecrine Mood reports preliminary data from exp... [Published GlobeNewswire: Acquisitions News - Jun 12 2014]
Saint Luke's awarded $3.4 million grant from Bo... [Published PR Newswire - Jan 27 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.